Obesity, Diabetes and Gastrointestinal Malignancy: The role of Metformin and other Anti-diabetic Therapy

Journal Title: Global Journal of Obesity, Diabetes and Metabolic Syndrome - Year 2018, Vol 5, Issue 2

Abstract

The association between Diabetes and cancer has been known for decades with obesity and insulin resistance being postulated as the main underlying risk factors for both disorders. With rise of the epidemic of obesity in the USA and around the globe, there has been a rise in diabetes that is currently reaching epidemic proportions. Diabetes is known to be associated with increased risk of several types of malignancy including breast, cervical, pancreatic and colon cancer. In this review, we discuss the epidemic of obesity and its consequential epidemic of diabetes highlighting the pathophysiologic mechanisms of increased cancer in the diabetic population. We will then discuss the role of insulin therapy as well as other antidiabetic medications, particularly metformin that has been to be associated with lower risk as well as better survival with GI malignancies based on several studies including a study that was recently published by our group.

Authors and Affiliations

M Ashamalla, I Youssef, A Jayarangaiah, N Gupta, S Iqbal, R Miller, SI McFarlane

Keywords

Related Articles

The Interaction between Metabolic Disease and Ageing

Two of the greatest crises that civilisation faces in the 21st century are the predicted rapid increases in the ageing population and levels of metabolic disorders such as obesity and type 2 diabetes. A growing amount of...

Diabetes mellitus and heart diseases

Diabetes mellitus is recognized by World Health Organisation experts as a non-communicable epidemic and represents a serious medical and social problem. In 2012, suffered of diabetes mellitus about 6.4% (285 million) of...

Breath Acetone as Biomarker for Lipid Oxidation and Early Ketone Detection

Former ketone studies, including ketoacidosis (KAD), fasting ketosis (FK), nutritional ketosis (NK), and exercis-eaffected ketosis have brought great advances to the field of ketones. In the present work, blood, urine an...

Sinapic Acid Regulates Glucose Homeostasis by Modulating the Activities of Carbohydrate Metabolizing Enzymes in High Fat Diet Fed-Low Dose STZ Induced Experimental Type 2 Diabetes in Rats

Diabetes Mellitus is a chronic metabolic disorder arises due to absolute lack of insulin secretion (T1DM) or its action or both (T2DM). Alterations in glucose metabolism in DM are frequently accompanied by impairment in...

Coronary Risk Estimation according to the Framingham-Wilson Score and Impaired Fasting Glucose in Adult Subjects from Maracaibo city, Venezuela

Introduction: Type 2 Diabetes Mellitus (T2DM) is an independent risk factor for coronary artery disease. Nevertheless, the coronary risk rendered by pre-diabetes states such as Impaired Fasting Glucose (IFG) has not been...

Download PDF file
  • EP ID EP533005
  • DOI 10.17352/2455-8583.000032
  • Views 66
  • Downloads 0

How To Cite

M Ashamalla, I Youssef, A Jayarangaiah, N Gupta, S Iqbal, R Miller, SI McFarlane (2018). Obesity, Diabetes and Gastrointestinal Malignancy: The role of Metformin and other Anti-diabetic Therapy. Global Journal of Obesity, Diabetes and Metabolic Syndrome, 5(2), 8-14. https://europub.co.uk./articles/-A-533005